[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.241.171. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
January 1991

Effect of Aerosolized Fibrin Solution on Intraperitoneal Contamination

Author Affiliations

From the Department of Surgery, Harbor-UCLA Medical Center, Torrance, Calif (Drs Dubrow, Schwartz, and Wilson); Maricopa Medical Center, Phoenix, Ariz (Dr McKissock); and UCLA School of Medicine, Los Angeles, Calif (Dr Wilson).

Arch Surg. 1991;126(1):80-83. doi:10.1001/archsurg.1991.01410250086014
Abstract

• The potential deleterious effects of aerosolized fibrin on contaminated procedures were investigated in a rat model of peritonitis. One hundred forty rats were divided into two groups. In the control group, gelatin capsules containing feces (107 bacteria per milliliter) and barium sulfate at various dilutions were placed into the abdomen; in the second experimental group, a solution of cryoprecipitate, thrombin, and calcium was sprayed diffusely into the peritoneal cavity after similar fecal contamination. Fecal inocula with low bacterial concentrations (0.01, 0.1, and 0.15 mL) caused few deaths from peritonitis or abscess formation in either group. Heavy peritoneal contamination (0.25, 0.3, and 0.5 mL) caused early deaths from peritonitis in both groups, with 80% of the deaths due to sepsis in the first 48 hours. However, in the moderately contaminated rats (0.2 mL) of fecal inoculate), fibrin aerosol reduced the 10-day mortality from 80% to 10%. In all survivors in the fibrin-treated group, intraperitoneal abscesses developed. With intraperitoneal bacterial concentrations of 2 × 106 organisms, early acute mortality from fibrinopurulent peritonitis is decreased at the expense of late, localized, nonlethal abscess formation. Aerosolized fibrin solution must be used with caution in contaminated surgery.

(Arch Surg. 1991;126:80-83)

References
1.
Lerner R, Binur NS.  Current status of surgical adhesives . J Surg Res . 1990;48:165-181.Article
2.
Koveker G.  Clinical application of fibrin glue in cardiovascular surgery . Thorac Cardiovasc Surg . 1982;30:228-229.Article
3.
Wolner E.  Fibrin gluing in cardiovascular surgery . Thorac Cardiovasc Surg . 1982;30:236-237.Article
4.
Rendaro F, Coco G, Quarto G, Rinaldo M, Castellitto D, Sarno A.  Valutazione sperimentale dell'effeto di rinforzo della colla di fibrina sulle anastomosi intestinali con un metodo originale in vivo . Boll Soc Ital Biol Sper . 1985;61:1335-1342.
5.
Harrison RC, Oka H.  Rectal anastomosis: sutures vs. staples and glue . Contemp Surg . 1982;21:17-21.
6.
Couto J, Kroczek B, Requena R, Lerner R.  Autologous fibrin glue as a sealant of the common bile duct . Surgery . 1987;101:354-357.
7.
Kram HB, Garces MA, Klein SR, Shoemaker WC.  Common bile duct anastomosis using fibrin glue . Arch Surg . 1985;120:1250-1252.Article
8.
Kirkegaard P, Madsen PV.  Lukning af fistler med fibrinklaeber . Ugeskr Laeger . 1982;144:3832-3836.
9.
Kirkland P, Madsen PV.  Peritoneal sinus after removal of the rectum: occlusion with fibrin adhesive . Am J Surg . 1983;145:791-794.Article
10.
Blocker SH, Ternberg J.  Traumatic liver laceration in the newborn: repair with fibrin glue . J Pediatr Surg . 1986;21:369-372.Article
11.
Jacob H, Campbell CD, Stemberger A. Wriedt-Lübbe I, Blumel G, Replogle R.  Combined application of heterologous collagen and fibrin sealant for liver injuries . J Surg Res . 1984;36:571-574.Article
12.
Kram HB, Hino ST, Harley DP, Fleming AW, Shoemaker WC.  Use of concentrated fibrinogen in experimental splenic trauma . J Biomed Mater Res . 1986;20:547-550.Article
13.
Scheele J, Gentsch HH, Matteson E.  Splenic repair by fibrin tissue adhesive and collagen fleece . Surgery . 1984;95:6-11.
14.
Ahrenholz DH, Simmons RL.  Fibrin in peritonitis, I: beneficial and adverse effects of fibrin in experimental E. coli peritonitis . Surgery . 1980;88:41-47.
15.
Hau T, Simmons RL.  Heparin in the treatment of experimental peritonitis . Ann Surg . 1978;187:294-298.Article
16.
Hudspeth AS.  Radical surgical débridement in the treatment of advanced generalized bacterial peritonitis . Arch Surg . 1975;110:1233-1239.Article
17.
Thadepalli H, Gorbach SL, Braido PW, Norsen J, Nyhus L.  Abdominal trauma, anaerobes and antibiotics . Surg Gynecol Obstet . 1973;137:270-276.
18.
Nichols RL, Smith JW, Klein DB, et al.  Risk of infection after penetrating abdominal trauma . N Engl J Med . 1984;311:1065-1070.Article
19.
Nichols RL, Smith JW, Balthazar ER.  Peritonitis and intra-abdominal abscess: an experimental model for the evaluation of human disease . J Surg Res . 1978;25:129-134.Article
20.
Coyle MB, Morello JA, Smith PB.  Aerobic bacteria . In: Lennette EH, Balows A, Hausler WJ Jr, Shadomy HJ, eds. Manual of Clinical Microbiology . 4th ed. Washington, DC: American Society for Microbiology; 1985:143-411.
21.
Dunn DL, Barke RA, Ahrenholz DH, Humphrey EW, Simmons RL.  The adjuvant effect of peritoneal fluid in experimental peritonitis: mechanism and clinical implications . Ann Surg . 1984;199:37-43.Article
22.
Cohn ZA.  Determinants of infection in the peritoneal cavity, I: response to and fate of Staphylococcus aureus and Staphylococcus albus in the mouse . Yale J Biol Med . 1962;35:12-61.
23.
Dunn DL, Simmons RL.  Fibrin in peritonitis, III: the mechanism of bacterial trapping by polymerizing fibrin . Surgery . 1982;92:513-519.
24.
Rotstein OD, Pruett TL, Simmons RL.  Fibrin inhibits phagocytic killing of Escherichia coli by human polymorphonuclear leukocytes . Ann Surg . 1988;203:413-419.Article
25.
Hau T, Payne WD, Simmons RL.  Fibrinolytic activity of the peritoneum during experimental peritonitis . Surg Gynecol Obstet . 1979;148:415-418.
×